|
Resolution: standard / high Figure 1.
Transforming growth factor (TGF)β signaling generally occurs through TGFβ type I and
type II receptors and Smads. TGFβ binds to the TGFβ type I and type II receptors.
The type I receptor contains kinase activity, and phosphorylates receptor-activated
Smads, Smad2 and Smad3, which dimerize with Smad4. The resultant complex migrates
into the nucleus to activate target gene expression. TGFβ induces the inhibitory Smads,
Smad6 and Smad7, which block TGFβ receptor type I-dependent Smad 2/3 activation.
Leask Arthritis Research & Therapy 2006 8:213 doi:10.1186/ar1976 |